CN1084403A

CN1084403A - Radioprotector and production technology thereof

Info

Publication number: CN1084403A
Application number: CN 93108122
Authority: CN
Inventors: 利国威
Original assignee: Individual
Current assignee: Individual
Priority date: 1993-07-02
Filing date: 1993-07-02
Publication date: 1994-03-30

Abstract

The present invention relates to a kind ofly in the radiotherapy of woman's cancer, be used to prevent and treat the radioprotector and the production technology thereof of radiation rectitis.Its constituent and each components in proportions are: Radix Glycyrrhizae 4～14%, Radix Saposhnikoviae 3～13%, Radix Salviae Miltiorrhizae 5～15%, Radix Astragali 6～16%, the Rhizoma Atractylodis Macrocephalae 7～17%, the Radix Paeoniae Alba 20～30%, Radix Scutellariae 14～24%, Rhizoma Corydalis 13～23%.This product is mainly used in the radiotherapy of woman's cancer, can prevent the generation of radiation rectitis effectively, alleviates patient's misery.

Description

Radioprotector and production technology thereof

The present invention relates to a kind ofly in the radiotherapy of woman's cancer, be used to prevent and treat the radioprotector and the production technology thereof of radiation rectitis.

After the internal radiotherapy machine of behaveing affectedly be applied to the radiotherapy of woman's cancer and progressively popularize at home, the radiation rectitis incidence rate that causes in the radiotherapy is higher, its cardinal symptom is frequency of bowel movement, tenesmus, stomachache, diarrhoea, just pain, Mucous Stool even hemafecia, severe patient often draws blood, be difficult to differentiate with the recurrence of intestinal metastatic carcinoma, often need go enteroscopy, have a strong impact on patient's work and life.The hospital that has adds and subtracts Chinese medicines such as oral or coloclysis and makes general enteritis symptomatic treatment with Radix Pulsatillae Decoction, but poor effect; The hospital that also has gives medicines such as antiinflammatory such as patient's berberine, petrolatum, local anaesthetics and carbazochrome salicylate, lubricated, pain relieving and hemostasis, does not deal with problems equally.

The object of the present invention is to provide a kind ofly in the radiotherapy of woman's cancer, can prevent radioprotector and production technology thereof that radiation rectitis takes place effectively.

Below in conjunction with embodiment the present invention is described in detail.

Constituent of the present invention and each components in proportions are: Radix Glycyrrhizae 4～14%, Radix Saposhnikoviae 3～13%, Radix Salviae Miltiorrhizae 5～15%, Radix Astragali 6～16%, the Rhizoma Atractylodis Macrocephalae 7～17%, the Radix Paeoniae Alba 20～30%, Radix Scutellariae 14～24%, Rhizoma Corydalis 13～23%.

Production technology of the present invention is:

1. extracting liquorice, Radix Saposhnikoviae, Radix Salviae Miltiorrhizae, Radix Astragali, the Rhizoma Atractylodis Macrocephalae, the Radix Paeoniae Alba, Radix Scutellariae, Rhizoma Corydalis place in stainless-steel pan or the enamel pan, add water logging and cross powder, and heat is carried 2 hours in the boiling water bath, uses filtered through gauze, get filtrate (I) and medicinal residues;

With medicinal residues as above method add hydro-thermal and carry 1 hour, filtered through gauze, medicinal residues discard, filtrate (II);

3. filtrate (I) is merged with water vapour with filtrate (II) and concentrate, till every milliliter of concentrated solution contains total crude drug 1.0g, adding 0.5% sodium benzoate stirs molten while hot, the reuse filtered through gauze, supplemental heat boiled water messenger drug is dense to meet the 1.0g/ml requirement, is sub-packed in the sky plastic bag every capsule 15ml, seal, sterilization promptly.

Embodiment:

1. extracting liquorice 6g, Radix Saposhnikoviae 7g, Radix Salviae Miltiorrhizae 6g, Radix Astragali 9g, Rhizoma Atractylodis Macrocephalae 9g, Radix Paeoniae Alba 25g, Radix Scutellariae 20g, Rhizoma Corydalis 18g place in stainless-steel pan or the enamel pan, add water logging and cross powder, and heat is carried 2 hours in the boiling water bath, uses filtered through gauze, get filtrate (I) and medicinal residues;

3. filtrate (I) and filtrate (II) merging are concentrated into 100ml with water vapour, add sodium benzoate 0.5g thermosol and stir evenly, the reuse filtered through gauze is sub-packed in the sky plastic bag, and every capsule 15ml seals, and sterilization promptly.

The invention is not restricted to an above-mentioned embodiment.

Before the radiotherapy, give 15ml coloclysis in woman's carninomatosis people behave affectedly after going for the first time, carry out radiotherapy then.Next day and the 3rd day, inferior on every Wendesdays, each capsule was until finishing omnidistance radiotherapy by patient's perfusion voluntarily.In the radiotherapy of woman's cancer, this product can prevent the generation of radiation rectitis effectively, alleviates patient's misery.

Claims

1, a kind of radioprotector and production technology thereof is characterized in that its constituent and each components in proportions are: Radix Glycyrrhizae 4～14%, Radix Saposhnikoviae 3～13%, Radix Salviae Miltiorrhizae 5～15%, Radix Astragali 6～16%, the Rhizoma Atractylodis Macrocephalae 7～17%, the Radix Paeoniae Alba 20～30%, Radix Scutellariae 14～24%, Rhizoma Corydalis 13～23%.

2, a kind of production technology of radioprotector is characterized in that:

A. extracting liquorice, Radix Saposhnikoviae, Radix Salviae Miltiorrhizae, Radix Astragali, the Rhizoma Atractylodis Macrocephalae, the Radix Paeoniae Alba, Radix Scutellariae, Rhizoma Corydalis water edulcoration place in stainless-steel pan or the enamel pan, add water logging and cross powder, and heat is carried 2 hours in the boiling water bath, uses filtered through gauze, get filtrate (I) and medicinal residues;

B. with medicinal residues as above method add hydro-thermal and carry 1 hour, filtered through gauze, medicinal residues discard, filtrate (II);

C. filtrate (I) is merged with water vapour with filtrate (II) and concentrate, till every milliliter of concentrated solution contains total crude drug 1.0g, adding 0.5% sodium benzoate stirs molten while hot, the reuse filtered through gauze, supplemental heat boiled water messenger drug is dense to meet the 1.0g/ml requirement, is sub-packed in the sky plastic bag every capsule 15ml, seal, sterilization promptly.